Microparticles in cardiovascular diseases.

[1]  J. Freyssinet,et al.  Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. , 1999, Blood.

[2]  B. Binder,et al.  Oxidized Membrane Vesicles and Blebs From Apoptotic Cells Contain Biologically Active Oxidized Phospholipids That Induce Monocyte‐Endothelial Interactions , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[3]  S. Narumiya,et al.  Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. , 1999, Science.

[4]  J. Roberts,et al.  Endothelial Dysfunction in Preeclampsia , 1998, Seminars in reproductive endocrinology.

[5]  R. Westendorp,et al.  Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. , 2000, Blood.

[6]  J. Neefjes,et al.  E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. , 1992, Immunology.

[7]  C. Gerard,et al.  Receptor-dependent internalization of platelet-activating factor. , 1994, Journal of immunology.

[8]  J. Griffin,et al.  Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. , 1991, Blood.

[9]  Y Komiyama,et al.  High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. , 1996, Blood.

[10]  M. Sefton,et al.  Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect. , 1993, The Journal of biological chemistry.

[11]  K. Chorneyko,et al.  Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. , 2000, Blood.

[12]  Y. Komiyama,et al.  Amyloid β-Protein Precursor-Rich Platelet Microparticles in Thrombotic Disease , 1994, Thrombosis and Haemostasis.

[13]  R. Nieuwland,et al.  Phospholipid composition of cell-derived microparticles determined by one-dimensional high-performance thin-layer chromatography. , 2002, Analytical biochemistry.

[14]  D. Steinberg,et al.  The oxidative modification hypothesis of atherosclerosis: does it hold for humans? , 2001, Trends in cardiovascular medicine.

[15]  B. Furie,et al.  Platelet-derived microparticles express high affinity receptors for factor VIII. , 1991, The Journal of biological chemistry.

[16]  P. Siljander,et al.  Platelet-derived microparticles associate with fibrin during thrombosis. , 1996, Blood.

[17]  M. Mesri,et al.  Leukocyte Microparticles Stimulate Endothelial Cell Cytokine Release and Tissue Factor Induction in a JNK1 Signaling Pathway* , 1999, The Journal of Biological Chemistry.

[18]  J. Freyssinet,et al.  Apoptosis in Vascular Disease , 1999, Thrombosis and Haemostasis.

[19]  J. Dacie,et al.  A Simple Method of Studying the Generation of Thrombin in Recalcified Plasma , 1953, Journal of clinical pathology.

[20]  J. Freyssinet,et al.  The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. , 1997, The Journal of clinical investigation.

[21]  F. Rodeghiero,et al.  Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation , 1997, British journal of haematology.

[22]  R. Nieuwland,et al.  Enhanced Coagulation Activation in Preeclampsia: the Role of APC Resistance, Microparticles and Other Plasma Constituents , 2002, Thrombosis and Haemostasis.

[23]  F. Contreras,et al.  Endothelial dysfunction in arterial hypertension , 2000, Journal of Human Hypertension.

[24]  P. Hinterdorfer,et al.  Ca(++)-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin. , 2002, Blood.

[25]  A. Zeiher,et al.  Vitamin C Inhibits Endothelial Cell Apoptosis in Congestive Heart Failure , 2001, Circulation.

[26]  H. Movat,et al.  The in vivo quantitation and kinetics of monocyte migration into acute inflammatory tissue. , 1981, The American journal of pathology.

[27]  G. Zimmerman,et al.  Novel leukocyte agonists are released by endothelial cells exposed to peroxide. , 1992, The Journal of biological chemistry.

[28]  A. Tedgui,et al.  Circulating Microparticles From Patients With Myocardial Infarction Cause Endothelial Dysfunction , 2001, Circulation.

[29]  M. Monden,et al.  Calpain activation in plasma membrane bleb formation during tert-butyl hydroperoxide-induced rat hepatocyte injury. , 1996, Gastroenterology.

[30]  K. Maquelin,et al.  Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. , 1997, Circulation.

[31]  G. FitzGerald,et al.  Modulation of monocyte-endothelial cell interactions by platelet microparticles. , 1998, The Journal of clinical investigation.

[32]  P. Bütikofer,et al.  Enrichment of two glycosyl-phosphatidylinositol-anchored proteins, acetylcholinesterase and decay accelerating factor, in vesicles released from human red blood cells. , 1989, Blood.

[33]  P. Baker,et al.  Isolated microparticles, but not whole plasma, from women with preeclampsia impair endothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women. , 2003, American journal of obstetrics and gynecology.

[34]  J. Fox,et al.  Role of the membrane skeleton in preventing the shedding of procoagulant-rich microvesicles from the platelet plasma membrane , 1990, The Journal of cell biology.

[35]  L. Horstman,et al.  Clinical significance of platelet microparticles in autoimmune thrombocytopenias. , 1992, The Journal of laboratory and clinical medicine.

[36]  E. Salzman,et al.  Association of localized Ca2+ gradients with redistribution of glycoprotein IIb-IIIa and F-actin in activated human blood platelets. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[37]  D. Glogar,et al.  Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. , 1997, Atherosclerosis.

[38]  J. Freyssinet,et al.  Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. , 1999, Circulation.

[39]  E. Fisher,et al.  Release of active tissue factor by human arterial smooth muscle cells. , 2000, Circulation research.

[40]  M. Olson,et al.  Platelet-activating factor: receptors and signal transduction. , 1993, The Biochemical journal.

[41]  Jason C. Mills,et al.  Apoptotic Membrane Blebbing Is Regulated by Myosin Light Chain Phosphorylation , 1998, The Journal of cell biology.

[42]  R. Bizios,et al.  Thrombin‐induced adherence of neutrophils to cultured endothelial monolayers: Increased endothelial adhesiveness , 1988, Journal of cellular physiology.

[43]  E. Dennis,et al.  Scavenger Receptors, Oxidized LDL, and Atherosclerosis , 2001, Annals of the New York Academy of Sciences.

[44]  D. Green,et al.  Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis. , 1992, Cancer research.

[45]  K. Hirata,et al.  Inhibition of endothelium-dependent arterial relaxation by oxidized phosphatidylcholine. , 2000, Atherosclerosis.

[46]  J. Freyssinet,et al.  Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. , 2000, Circulation.

[47]  S. Nomura,et al.  High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells. , 2001, Atherosclerosis.

[48]  A. Schroit,et al.  Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. , 1997, Blood.

[49]  M. U. Nollert,et al.  Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. , 2000, Blood.

[50]  T. Marwick,et al.  Vascular dysfunction and heart failure: epiphenomenon or etiologic agent? , 2002, American heart journal.

[51]  G. Kroemer,et al.  Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death , 1995, The Journal of experimental medicine.

[52]  H. Brühl,et al.  Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: A mechanism for cellular human immunodeficiency virus 1 infection , 2000, Nature Medicine.

[53]  T. Mori,et al.  The role of protein phosphorylation and cytoskeletal reorganization in microparticle formation from the platelet plasma membrane. , 1994, The Biochemical journal.

[54]  J. Freyssinet,et al.  Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. , 1994, Journal of immunology.

[55]  C. Hack,et al.  Cell-derived Microparticles Circulate in Healthy Humans and Support Low Grade Thrombin Generation , 2001, Thrombosis and Haemostasis.

[56]  F. Basse,et al.  Correlation between inhibition of cytoskeleton proteolysis and anti-vesiculation effect of calpeptin during A23187-induced activation of human platelets: are vesicles shed by filopod fragmentation? , 1994, Biochimica et biophysica acta.

[57]  F. Breedveld,et al.  Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. , 2002, Arthritis and rheumatism.

[58]  J. Liao,et al.  Endothelium and acute coronary syndromes. , 1998, Clinical chemistry.

[59]  G. Grau,et al.  In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. , 1999, The Journal of clinical investigation.

[60]  K S Sakariassen,et al.  Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[61]  T. Shimazu,et al.  Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. , 2001, The Journal of trauma.

[62]  C. Byrne,et al.  Activated protein C resistance: effect of platelet activation, platelet-derived microparticles, and atherogenic lipoproteins. , 1999, Blood.

[63]  C. Esmon,et al.  Infusion of Phospholipid Vesicles Amplifies the Local Thrombotic Response to TNF and Anti-Protein C into a Consumptive Response , 1996, Thrombosis and Haemostasis.

[64]  C. Esmon,et al.  Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. , 1990, The Journal of biological chemistry.

[65]  P. Sims,et al.  Participation of protein kinases in complement C5b-9-induced shedding of platelet plasma membrane vesicles. , 1991, Blood.

[66]  H. Shiku,et al.  Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation , 1996, American journal of hematology.

[67]  A. Allegra,et al.  Is apoptosis cause of pre-eclampsia? , 1998, European review for medical and pharmacological sciences.

[68]  C. Hack,et al.  Microparticles from Patients with Multiple Organ Dysfunction Syndrome and Sepsis Support Coagulation through Multiple Mechanisms , 2001, Thrombosis and Haemostasis.

[69]  L. Sarda,et al.  Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells , 1995, Cell.

[70]  L. Horstman,et al.  Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. , 1993, Thrombosis research.

[71]  R. Nieuwland,et al.  Microparticle subpopulations are increased in preeclampsia: possible involvement in vascular dysfunction? , 2002, American journal of obstetrics and gynecology.

[72]  H. Hemker,et al.  Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis". , 1996, The Journal of clinical investigation.

[73]  G. FitzGerald,et al.  Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. , 1997, The Journal of clinical investigation.

[74]  A. Tedgui,et al.  Current perspective on the role of apoptosis in atherothrombotic disease. , 2001, Circulation research.

[75]  T. Terao,et al.  Annexin V inhibits phosphatidylserine-induced intrauterine growth restriction in mice. , 1999, Placenta.

[76]  Y. Ikeda,et al.  Platelet-derived microparticles in patients with arteriosclerosis obliterans: enhancement of high shear-induced microparticle generation by cytokines. , 2000, Thrombosis research.

[77]  C. Esmon,et al.  Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. , 1989, The Journal of biological chemistry.

[78]  G. Pellegrini,et al.  P-selectin induces the expression of tissue factor on monocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[79]  A. Régnault,et al.  TCR Activation of Human T Cells Induces the Production of Exosomes Bearing the TCR/CD3/ζ Complex1 , 2002, The Journal of Immunology.

[80]  E. Sahai,et al.  Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I , 2001, Nature Cell Biology.

[81]  H. Lutz,et al.  Release of vesicles enriched in complement receptor 1 from human erythrocytes. , 1993, Journal of immunology.

[82]  S. Nomura,et al.  Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. , 1995, Atherosclerosis.

[83]  P. Wolf.  The Nature and Significance of Platelet Products in Human Plasma , 1967, British journal of haematology.

[84]  G. Zimmerman,et al.  Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor. , 1991, The Journal of biological chemistry.

[85]  R. Becker.  Anticoagulation and the Heart , 2001, Journal of Thrombosis and Thrombolysis.

[86]  L. Horstman,et al.  Platelet microparticles bind, activate and aggregate neutrophils in vitro. , 1995, Blood cells, molecules & diseases.

[87]  G. Zimmerman,et al.  Platelet-activating factor mediates procoagulant activity on the surface of endothelial cells by promoting leukocyte adhesion. , 1995, Seminars in cell biology.

[88]  M. Mesri,et al.  Endothelial cell activation by leukocyte microparticles. , 1998, Journal of immunology.

[89]  P. Sims,et al.  Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. , 1988, The Journal of biological chemistry.

[90]  J. Fox.  The Platelet Cytoskeleton , 1993, Thrombosis and Haemostasis.

[91]  S. Nomura,et al.  Antiplatelet autoantibody-related microparticles in patients with idiopathic (autoimmune) thrombocytopenic purpura , 1991, Annals of Hematology.